Osteotec re-launches Silicone Finger Implant into UK and international markets

NEWBURY, EnglandDec. 9, 2024 /PRNewswire/ — Osteotec, the market-leading manufacturer and distributor of medical devices, is pleased to announce the re-launch of the Osteotec Silicone Finger Implant in markets accepting CE-marked medical devices, following its successful certification under the European Medical Device Regulation (MDR).

This significant milestone was achieved after two years of rigorous regulatory work by Osteotec’s legal, quality, and regulatory teams, and underscores the company’s commitment to providing high-quality, British-made solutions in an increasingly complex regulatory environment.

The Osteotec Silicone Finger Implant has remained available and widely used in FDA markets, and the reintroduction of CE certification is expected to drive global sales and increase access to the product for surgeons worldwide.

The one-piece, sterile, flexible silicone elastomer implant has been designed for arthroplasty of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints, offering a reliable solution for patients suffering from osteoarthritis, rheumatoid arthritis or joint trauma.

“We are incredibly excited to reintroduce the Osteotec Silicone Finger Implant to both our UK and international customers,” said Anthony McClellan, Group General Manager of Osteotec. “Navigating the MDR transition has been a significant challenge for the entire industry, and particularly for independent businesses.

“However, thanks to our dedicated teams and our strong partnerships with our notified body TÜV SÜD and the Compliant Medical Devices Ltd consultancy, we’ve been able to meet these regulatory requirements and continue offering a world-class solution for small joint arthroplasty.”

The Osteotec Silicone Finger Implant has been widely used in hand surgery over the past two decades, delivering consistent, positive outcomes for patients requiring joint replacement due to arthritis or trauma since it was launched in 2004.

“As a proud UK-based manufacturer, we have made a substantial investment to ensure the long-term availability of this essential product,” said Dean Stockwell, Sales and Marketing Director at Osteotec.

“The Osteotec Silicone Finger Implant stands out as a British innovation that delivers tangible benefits to surgeons and patients alike. Our re-launch comes at a time when the regulatory environment has made it increasingly difficult for independent companies to thrive, but we remain committed to improving patient outcomes both in the UK and internationally.”

This re-launch represents a major landmark in Osteotec’s commitment to providing innovative, high-quality medical devices to the orthopaedic and small joint surgery sectors.

About Osteotec

Osteotec is a leading medical device manufacturer and distributor, headquartered in Newbury, UK, with offices in Dublin, Ireland, and Malmö, Sweden. Specialising in small joint solutions, Osteotec has a reputation for delivering high-quality, clinically proven products to improve patient outcomes in orthopaedic surgery.

Osteotec manufactures and distributes the Osteotec Silicone Finger, ChiroKlip and the Concentric Bone Graft System and is a distributor for world-leading orthopaedic partners including SI-BONE, TriMed, Enovis and Mathys.

Media Contact

Harriet Bawden
Marketing Manager
mkt@osteotec.com | 020 3011 5574
For more information, visit – www.osteotec.com

SOURCE Osteotec